[HTML][HTML] Complement factor I promotes progression of cutaneous squamous cell carcinoma
P Riihilä, L Nissinen, M Farshchian, A Kivisaari… - Journal of Investigative …, 2015 - Elsevier
The incidence of cutaneous squamous cell carcinoma (cSCC) is rising worldwide. We have
examined the role of complement components in the progression of cSCC. Analysis of cSCC …
examined the role of complement components in the progression of cSCC. Analysis of cSCC …
[HTML][HTML] Complement component C3 and complement factor B promote growth of cutaneous squamous cell carcinoma
P Riihilä, L Nissinen, M Farshchian, M Kallajoki… - The American Journal of …, 2017 - Elsevier
Cutaneous squamous cell carcinoma (cSCC) is one of the most common metastatic skin
cancers with increasing incidence. We examined the roles of complement component C3 …
cancers with increasing incidence. We examined the roles of complement component C3 …
[HTML][HTML] Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma
PM Riihilä, LM Nissinen, R Ala-Aho, M Kallajoki… - Journal of Investigative …, 2014 - Elsevier
The incidence of cutaneous squamous cell carcinoma (cSCC) is increasing globally. We
have studied the expression of complement system components in cSCC. Expression …
have studied the expression of complement system components in cSCC. Expression …
Tumour‐cell‐derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma
P Riihilä, K Viiklepp, L Nissinen… - British Journal of …, 2020 - academic.oup.com
Background The incidence of epidermal keratinocyte‐derived cutaneous squamous cell
carcinoma (cSCC) is increasing worldwide. Objectives To study the role of the complement …
carcinoma (cSCC) is increasing worldwide. Objectives To study the role of the complement …
Complement system in cutaneous squamous cell carcinoma
P Riihilä, L Nissinen, J Knuutila… - International Journal of …, 2019 - mdpi.com
Epidermal keratinocyte-derived cutaneous squamous cell carcinoma (cSCC) is the most
common metastatic skin cancer with high mortality rates in the advanced stage. Chronic …
common metastatic skin cancer with high mortality rates in the advanced stage. Chronic …
Complement factor I upregulates expression of matrix metalloproteinase‐13 and‐2 and promotes invasion of cutaneous squamous carcinoma cells
P Rahmati Nezhad, P Riihilä… - Experimental …, 2021 - Wiley Online Library
The incidence of cutaneous squamous cell carcinoma (cSCC) is increasing globally. Here,
we have studied the functional role of complement factor I (CFI) in the progression of cSCC …
we have studied the functional role of complement factor I (CFI) in the progression of cSCC …
Complement factor D is a novel biomarker and putative therapeutic target in cutaneous squamous cell carcinoma
P Rahmati Nezhad, P Riihilä, JS Knuutila, K Viiklepp… - Cancers, 2022 - mdpi.com
Simple Summary The incidence of the most common metastatic skin malignancy, cutaneous
squamous cell carcinoma (cSCC), is growing worldwide, and the prognosis of the metastatic …
squamous cell carcinoma (cSCC), is growing worldwide, and the prognosis of the metastatic …
Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma
Z Fan, J Qin, D Wang, S Geng - Journal of Cellular and …, 2019 - Wiley Online Library
Background Complement C3 has been shown to be highly expressed in cutaneous
squamous cell carcinoma (cSCC) tumour tissues and is correlated with tumour cell growth …
squamous cell carcinoma (cSCC) tumour tissues and is correlated with tumour cell growth …
[HTML][HTML] C3 drives inflammatory skin carcinogenesis independently of C5
WD Jackson, A Gulino, L Fossati-Jimack… - Journal of Investigative …, 2021 - Elsevier
Nonmelanoma skin cancer such as cutaneous squamous cell carcinoma (cSCC) is the most
common form of cancer and can occur as a consequence of DNA damage to the epithelium …
common form of cancer and can occur as a consequence of DNA damage to the epithelium …
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence
M Okroj, E Holmquist, E Nilsson, L Anagnostaki… - Cancer Immunology …, 2015 - Springer
Tumor cells often evade killing by the complement system by overexpressing membrane-
bound complement inhibitors. However, production of soluble complement inhibitors in cells …
bound complement inhibitors. However, production of soluble complement inhibitors in cells …
相关搜索
- cell carcinoma complement factor
- biomarker for progression complement factor
- cell carcinoma biomarker for progression
- tumour cell complement components
- local expression complement factor
- poor survival complement factor
- matrix metalloproteinase complement factor
- matrix metalloproteinase carcinoma cells
- cell carcinoma c1r and c1s
- cell carcinoma complement components